ductal breast carcinoma cell line (ATCC)


Structured Review

Ductal Breast Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ductal breast carcinoma cell line/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937"
Article Title: Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937
Journal: BMC Cancer
doi: 10.1186/1471-2407-6-297

Figure Legend Snippet: Expression of antioxidants in HCC1937 and MCF-7 relative to AG11134 . Western Blot analysis of SOD1, SOD2 and catalase showing their levels in the two breast cancer cell lines compared to the normal mammary epithelial cell line, AG11134. β-actin was used as a loading control. The gels are representatives of three independent analyses in each case.
Techniques Used: Expressing, Western Blot
hcc1937 crl 2336 cell lines (ATCC)


Structured Review
Hcc1937 Crl 2336 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc1937 crl 2336 cell lines/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
hcc1937 crl 2336 (ATCC)


Structured Review
Hcc1937 Crl 2336, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc1937 crl 2336/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
ductal breast carcinoma cell line (ATCC)


Structured Review

Ductal Breast Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ductal breast carcinoma cell line/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937"
Article Title: Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937
Journal: BMC Cancer
doi: 10.1186/1471-2407-6-297

Figure Legend Snippet: Expression of antioxidants in HCC1937 and MCF-7 relative to AG11134 . Western Blot analysis of SOD1, SOD2 and catalase showing their levels in the two breast cancer cell lines compared to the normal mammary epithelial cell line, AG11134. β-actin was used as a loading control. The gels are representatives of three independent analyses in each case.
Techniques Used: Expressing, Western Blot
hcc1937 cells (ATCC)


Structured Review
Hcc1937 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc1937 cells/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
hcc1937 cells (ATCC)


Structured Review

Hcc1937 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc1937 cells/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer"
Article Title: GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer
Journal: Theranostics
doi: 10.7150/thno.59280

Figure Legend Snippet: BRCA1 positively regulates GATA3 expression in breast cancer cells and tissues. (A, B) Mammary tumor tissues (A) or primary tumor cells (B) from p18 -/- and p18 -/- ;Brca1 MGKO mice were analyzed by western blot (A) or qRT-PCR (B). N.S., non-specific band. Data in (B) represent the mean ± SD. from triplicates of two independent primary cell lines of each genotype. The asterisk (*) in (B) denotes a statistical significance from p18 -/- and p18 -/- ;Brca1 MGKO samples determined by the T-test. (C, D) The mRNA and protein levels of BRCA1 and GATA3 in human breast cell lines were detected by qRT-PCR (C) and Western blot (D). BRCA1 and GATA3 mRNA levels in breast cancer cell lines were normalized to that of MCF-10A cell line. Data in (C) represent the mean ± SD from triplicates of each of the two independent experiments. The asterisk (*) denotes a statistical significance from MCF-10 and breast cancer cell lines determined by the T-test. (E) T47D cells were infected with either pGIPZ-empty (sh-Ctrl) or pGIPZ-sh-BRCA1 (sh-BRCA1). Cells stably expressing sh-Ctrl or sh-BRCA1 were analyzed by qRT-PCR. Data represent the mean ± SD from triplicate of each of the two independent experiments. The asterisk (*) denotes a statistical significance from sh-Ctrl and sh-BRCA1 samples determined by the T-test. (F) HCC1937 cells were transfected with pBabe-empty (Empty) or pBabe-HA-BRCA1 (BRCA1). Expression of genes indicated were determined by western blot 48 hours after transfection. (G) PDX tumors generated by BRCA1 WT and BRCA1 mutant (Mut) breast cancers were stained with antibodies against GATA3 and Vim. GATA3 positive tumor cells (arrows in inset) and luminal epithelial cells (arrowheads) in mouse endogenous mammary glands are indicated. The H-scores for GATA3 and Vim in IHC were calculated. The results represent the mean ± SD of four individual tumors per group. The asterisk (*) denotes a statistical significance from BRCA1 WT PDX and BRCA1 Mut PDX samples determined by the T-test.
Techniques Used: Expressing, Western Blot, Quantitative RT-PCR, Infection, Stable Transfection, Transfection, Generated, Mutagenesis, Staining

Figure Legend Snippet: GATA3 gene is hypermethylated in BRCA1 -deficient cells, and depletion of BRCA1 in BRCA1 proficient cells stimulates methylation of GATA3 gene. (A, B, C) Human breast cancer cells were treated with either DMSO (Veh) or DAC (5 µM) for 72 hours, and then analyzed by qRT-PCR (A) and western blot (B, C). Triple the amount of protein lysates from HCC1937 in (B) were analyzed in (C). MDA231, MDA-MB-231. Note the drastic increase of GATA3 mRNA and protein in DAC-treated HCC1937 cells. (D, E) MS-PCR analysis of GATA3 promoter methylation for a panel of cell lines (D), as well as HCC1937 and MDA231 cells treated with Veh or DAC for 72 hours (E). U, unmethylated; M, methylated. (F, G, H) MCF7 cells infected with either pGIPZ-empty (sh-Ctrl) or pGIPZ-shBRCA1 targeting different sequences of human BRCA1 (sh-BRCA1-G6, and sh-BRCA1-B7) were treated with or without DAC for 72 hours and then analyzed by qRT-PCR (F), western blot (G), or MS-PCR analysis of GATA3 promoter methylation (H). (I) p18 -/- and p18 -/- ;Brca1 MGKO mammary tumor cells were treated with either Veh or DAC (5 µM) for 72 hours, and then analyzed by qRT-PCR. (UM11) and (UM12) represent two independent primary cell lines derived from two individual mice ( p18 -/- ;Brca1 MGKO ). Data in (A), (F), and (I) represent the mean ± SD from triplicates of each of the two independent experiments. The asterisk (*) denotes a statistical significance from DAC and Veh treated samples, or from sh-Ctrl and sh-BRCA1-G6 or sh-BRCA1-B7 samples determined via student T-test.
Techniques Used: Methylation, Quantitative RT-PCR, Western Blot, Infection, Derivative Assay
hcc1937 breast cancer cells (ATCC)


Structured Review
Hcc1937 Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc1937 breast cancer cells/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
brca1 mutant hcc1937 tnbc cells (ATCC)


Structured Review

Brca1 Mutant Hcc1937 Tnbc Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brca1 mutant hcc1937 tnbc cells/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage"
Article Title: RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage
Journal: BMC Cancer
doi: 10.1186/s12885-022-10119-z

Figure Legend Snippet: Lack of association between BRCA1 status and centrosome number and paclitaxel (PTX) response. A TNBC cell lines were fixed and immunostained with anti-pericentrin antibody. Nuclei were counterstained with DAPI. Bar, 10 µm. B Centrosome number quantification. Approximately 75 cells in four to six fields were scored for centrosome number. Data are shown as mean ± S.E.M from at least 2 independent experiments. Bars, 10 µm. C PTX sensitivities of BRCA1 wild type MDA-MB-231, MDA-MB-468, and BRCA1 mutant SUM1315 and HCC1937 TNBC cell lines measured by MTT assays. Results are expressed as mean ± S.D. of three independent experiments
Techniques Used: Mutagenesis

Figure Legend Snippet: SMI#9 synergistically enhances paclitaxel (PTX) sensitivity in BRCA1 wild type and mutant TNBC cell lines . MDA-MB-468 ( A-C ) and HCC1937 ( D-F ) cells were treated with PTX alone at the indicated concentrations or along with 0.75 µM SMI#9 and proliferating cells measured by MTT assays. C, F Combination indices (CI) were calculated with the CompuSyn software where a CI > 1 indicates antagonism, CI < 1 indicates synergy, and CI = 1 indicates an additive effect. Results are expressed as mean ± S.E.M from three independent experiments. * P < 0.05, ** P < 0.005, **** P < 0.00005
Techniques Used: Mutagenesis, Software

Figure Legend Snippet: RAD6 inhibition induces multinucleation and giant nuclei formation . MDA-MB-468 ( A-C ) and HCC1937 ( D-F ) cells were treated with the indicated doses of paclitaxel (PTX) for 24 h, and 100 viable cells were replated as single cells in quadruplicates post PTX treatment. Colonies were allowed to form and were then either left untreated or treated with 0.75 µM SMI#9. A , D Colony forming efficiency. A ** P < 0.005 and one-way ANOVA, P = 0.022; D * P < 0.01, ** P < 0.005 and one-way ANOVA, P = 0.0002. B, E Quantitation of colonies containing giant or multinucleated abnormal cells. Results are expressed as mean ± S.E.M. of replicates. E One-way ANOVA, P = 0.038. C, F Representative phase contrast images (long arrow, multinucleated cells; short arrow, cell with giant nucleus). Scale bars, 20 μM
Techniques Used: Inhibition, Quantitation Assay

Figure Legend Snippet: Paclitaxel and SMI#9 decrease 1N3R TAU isoform and modulate cyclin B1 protein levels differently in paclitaxel-sensitive and intrinsically resistant TNBC cells . Western blot analysis of the indicated proteins in MDA-MB-468 ( A, B ) and HCC1937 ( C-E ) cells treated with PTX, SM#9 or SMI#9 + PTX at the indicated nanomolar concentrations. E Cyclin B1 analysis in MG132 treated HCC1937 cells. B, D Protein levels were normalized to β-actin using Image J software
Techniques Used: Western Blot, Software

Figure Legend Snippet: Paclitaxel and SMI#9 induce accumulation of tetraploid cells in S and G2/M phases . DNA content analyzed by flow cytometry after 24 and 48 h of treatment with PTX (5 nM for MDA-MB-468 and 10 nM for HCC1937 cells), SMI#9 (0.75 µM) or a combination of SMI#9 with the corresponding PTX dose. A, B MDA-MB-468 and ( C, D ) HCC1937 cells. B, D Percentage of cells in diploid and tetraploid G1, S and G2/M phases were estimated after analysis using Modfit software
Techniques Used: Flow Cytometry, Software

Figure Legend Snippet: SMI#9 induces monopolar mitotic spindles . MDA-MB-468 ( A, B ) and HCC1937 ( C, D ) TNBC cells were treated with 2.5 or 10 nM PTX, respectively, 0.75 µM SMI#9 or SMI#9 + PTX and analyzed for TAU (green) and α-tubulin (red) expression/localization by immunofluorescence staining. Bar, 10 µm. Enlarged images of α-tubulin stained mitotic spindles are shown. B, D Quantitation of total TAU positive cells and those with monopolar mitotic spindles. Results are expressed as mean ± S.E.M of replicates. B * P < 0.05, C * P < 0.01
Techniques Used: Expressing, Immunofluorescence, Staining, Quantitation Assay
hcc1937 cells (ATCC)


Structured Review

Hcc1937 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc1937 cells/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Nimbolide Targets RNF114 to Induce the Trapping of PARP1 and Poly-ADP-Ribosylation-Dependent DNA Repair Factors"
Article Title: Nimbolide Targets RNF114 to Induce the Trapping of PARP1 and Poly-ADP-Ribosylation-Dependent DNA Repair Factors
Journal: bioRxiv
doi: 10.1101/2022.10.04.510815

Figure Legend Snippet: Structure of nimbolide ( a ) and a nimbolide analog ( b ). The compound as shown in ( b ) was inactive against UWB1 cells (IC 50 > 10 μM). Additional nimbolide analogs are shown in . c, RNF114 deletion abolishes the nimbolide-induced PARP1 trapping. HCT116 control (RNF114-WT) or HCF116 RNF114-KO cells were treated with nimbolide (1 μM for 24 hrs). The cells were subject to subcellular fractionation, and the chromatin fraction was analyzed by immunoblot assays using the indicated antibodies. d, Nimbolide treatment induces potent PARP1 trapping. Control (RNF114-WT) or RNF114-KO HeLa cells expressing GFP-tagged PARP1 were pre-treated with Olaparib (10 μM) or nimbolide (1 μM) for 1 h. GFP signals were monitored in a time-course experiment following laser microirradiation. The quantification results are shown in the right panel. Scale Bars, 10 μm. The level of PARP1 trapping (relative max intensity) was quantified by dividing the GFP signal from trapped PARP1 (trapped PARP1-GFP, combined across the different time points) by the total GFP signal in the nucleus (total PARP1-GFP, combined across the different time points). The level of PARP1 trapping for the different RNF114 conditions was then normalized to that in the RNF114-WT, DMSO sample. e, Nimbolide, but not Olaparib treatment, induces the trapping of XRCC1. HeLa cells expressing GFP-tagged XRCC1 were pre-treated with Olaparib (1 μM) or nimbolide (1 μM) for 1 h. These cells were subject to a laser microirradiation assay. GFP signals were monitored and were calculated in a time course. The quantification results are shown in the right panel. Scale bars, 10 μm. f, Nimbolide blocks the auto-ubiquitination of RNF114 in an in vitro ubiquitination assay. Where indicated, GST-RNF114 was incubated with E1/E2/ubiquitin in the presence of nimbolide (1 μM). g, RNF114 deletion rescues cells from nimbolide-induced cell death. Control (RNF114-WT) or RNF114-KO HeLa cells were treated with nimbolide (1 μM) for 24 hrs. Cells were lysed and the whole cell lysates were subject to immunoblotting analyses using the indicated antibodies. The deletion of RNF114 was confirmed as shown in . h, Control (RNF114-WT) or RNF114-KO HeLa cells were treated with nimbolide (1 μM) for 24 hrs, and cell viability was quantified using the CellTiter-Glo assay. The deletion of RNF114 was confirmed as shown in . i, PARP1 deletion rescues cells from nimbolide-induced cell death. Control (PARP1-WT) or PARP1-KO HeLa cells were treated with nimbolide (1 μM) for 24 hrs, and cell viability was quantified using the CellTiter-Glo assay. The deletion of PARP1 was confirmed as shown in . j, Nimbolide treatment is synthetic lethal with respect to BRCA1 -deficiency. UWB1 and UWB1+BRCA1 cells were subject to nimbolide treatment for 96 hrs. Viability was measured using a CellTiter-Glo assay. k, Nimbolide induces stronger cytotoxicity in UWB1 cells, compared to Olaparib. The cells were treated with the indicated compound for 96 hrs. Viability was measured using a CellTiter-Glo assay. l, m, Nimbolide overcomes intrinsic and acquired resistance to PARPi. l, HCC1937 cells were treated with nimbolide (1 μM) or PARPi (Olaparib and Rucaparib; 1 μM) for 96 hrs. Cell viability was measured using a CellTiter-Glo assay. m, UWB1 (SYr12) cells were treated with nimbolide or Olaparib for 96 hrs. Cell viability was measured using a CellTiter-Glo assay.
Techniques Used: Fractionation, Western Blot, Expressing, In Vitro, Ubiquitin Assay, Incubation, Glo Assay
hcc1937 cells (ATCC)


Structured Review

Hcc1937 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc1937 cells/product/ATCC
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer"
Article Title: MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer
Journal: Frontiers in Oncology
doi: 10.3389/fonc.2022.868866

Figure Legend Snippet: Effects of MOF inhibition on ERα protein expression and cell viability in ERα− HCC1937 cells. (A) MOF knockdown restored ERα protein abundance in ERα− HCC1937 cells transfected with pGPU6-shMOF plasmid as determined by Western blotting. (B) Different concentration of MOF inhibitor MG-149 was applied to examine its enhanced effect on ERα protein expression in MCF7 cells. (C) ERα protein expression was reactivated by 35 μM MG149 in ERα− HCC1937 cells. (D) Cell viability assay was performed to investigate the effect of MG149 on the sensitivity of ERα− HCC1937 cells to tamoxifen (TAM) treatment. IC 50 was calculated to compare the combinatory effect of TAM and MG149 with TAM alone treatment for 24 h.
Techniques Used: Inhibition, Expressing, Transfection, Plasmid Preparation, Western Blot, Concentration Assay, Viability Assay
hcc1937 crl 2336 (ATCC)


Structured Review
Hcc1937 Crl 2336, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc1937 crl 2336/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99